Drug Database
Back to search

United Kingdom· GB-APID-28426011000001108

Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens

A exenatide product containing exenatide, registered in United Kingdom by AstraZeneca UK Ltd. The same ATC class is registered in 10 of our 19 countries.

ATC A10BJ01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedBydureon 2mg powder and solvent for p…ATCA10BJ01REGISTER NO.GB-APID-2842601100000…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about exenatideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Exenatide is registered in 10 of 19 countries.

Countries holding a registration under ATC A10BJ01 (exenatide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose
Search exenatide products by name

Exenatide · ATC A10BJ01

10 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of exenatide costs, country by country.

Normalised to the WHO defined daily dose (15 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Exenatide · price per daily dose (15 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.26
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Exenatide
Manufacturer
AstraZeneca UK Ltd
Country
United Kingdom (GB)
ATC code
A10BJ01
ATC class
Exenatide
Defined daily dose
15 mcg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5000456007191

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

404 interactions on record for exenatide.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check exenatide against other medicinesHow interaction checks work

Exenatide · interactions on record

404 records

  • 3 severe
  • 359 moderate
  • 42 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • MannitolA06AD16moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Exenatide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All exenatide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5acfd76f-7b1a-4e61-96a2-ba1a97f1782c
GET /v1/drugs/5acfd76f-7b1a-4e61-96a2-ba1a97f1782c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "28426011000001108",
  "desc": "Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd)",
  "form": "Powder and solvent for prolonged-release suspension for inj",
  "vpid": "28440211000001102",
  "source": "dmd",
  "vtm_id": "775913009",
  "strength": "2 mg",
  "substance": "Exenatide",
  "ingredient": "Exenatide",
  "supplier_code": "3583301000001102"
}
API referenceMCP serverPlans

See everything about exenatide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console